[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Marburg Hemorrhagic Fever Drug Market Report 2018

March 2018 | 96 pages | ID: UBAFC3C9802QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Marburg Hemorrhagic Fever Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Marburg Hemorrhagic Fever Drug in these regions, from 2013 to 2025 (forecast).
United States Marburg Hemorrhagic Fever Drug market competition by top manufacturers/players, with Marburg Hemorrhagic Fever Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GlaxoSmithKline plc
  • Immunovaccine, Inc.
  • Integrated BioTherapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Tekmira Pharmaceuticals Corp.
  • Vaxart, Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Marburg Vaccine
  • AVI-7288
  • TKM-Marburg
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Marburg Hemorrhagic Fever Drug Market Report 2018

1 MARBURG HEMORRHAGIC FEVER DRUG OVERVIEW

1.1 Product Overview and Scope of Marburg Hemorrhagic Fever Drug
1.2 Classification of Marburg Hemorrhagic Fever Drug by Product Category
  1.2.1 United States Marburg Hemorrhagic Fever Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Marburg Hemorrhagic Fever Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Marburg Vaccine
  1.2.4 AVI-7288
  1.2.5 TKM-Marburg
  1.2.6 Others
1.3 United States Marburg Hemorrhagic Fever Drug Market by Application/End Users
  1.3.1 United States Marburg Hemorrhagic Fever Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Marburg Hemorrhagic Fever Drug Market by Region
  1.4.1 United States Marburg Hemorrhagic Fever Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
  1.4.5 New England Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
  1.4.6 The South Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Marburg Hemorrhagic Fever Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Marburg Hemorrhagic Fever Drug (2013-2025)
  1.5.1 United States Marburg Hemorrhagic Fever Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Marburg Hemorrhagic Fever Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Marburg Hemorrhagic Fever Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Marburg Hemorrhagic Fever Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Marburg Hemorrhagic Fever Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Marburg Hemorrhagic Fever Drug Market Competitive Situation and Trends
  2.4.1 United States Marburg Hemorrhagic Fever Drug Market Concentration Rate
  2.4.2 United States Marburg Hemorrhagic Fever Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Marburg Hemorrhagic Fever Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Marburg Hemorrhagic Fever Drug Sales and Market Share by Region (2013-2018)
3.2 United States Marburg Hemorrhagic Fever Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Marburg Hemorrhagic Fever Drug Price by Region (2013-2018)

4 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Marburg Hemorrhagic Fever Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Marburg Hemorrhagic Fever Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Marburg Hemorrhagic Fever Drug Price by Type (2013-2018)
4.4 United States Marburg Hemorrhagic Fever Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Marburg Hemorrhagic Fever Drug Sales and Market Share by Application (2013-2018)
5.2 United States Marburg Hemorrhagic Fever Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Immunovaccine, Inc.
  6.2.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Integrated BioTherapeutics, Inc.
  6.3.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sarepta Therapeutics, Inc.
  6.4.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Tekmira Pharmaceuticals Corp.
  6.5.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Vaxart, Inc
  6.6.2 Marburg Hemorrhagic Fever Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview

7 MARBURG HEMORRHAGIC FEVER DRUG MANUFACTURING COST ANALYSIS

7.1 Marburg Hemorrhagic Fever Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Marburg Hemorrhagic Fever Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Marburg Hemorrhagic Fever Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Marburg Hemorrhagic Fever Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MARBURG HEMORRHAGIC FEVER DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Marburg Hemorrhagic Fever Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Marburg Hemorrhagic Fever Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Marburg Hemorrhagic Fever Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Marburg Hemorrhagic Fever Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Marburg Hemorrhagic Fever Drug
Figure United States Marburg Hemorrhagic Fever Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Marburg Vaccine Product Picture
Figure AVI-7288 Product Picture
Figure TKM-Marburg Product Picture
Figure Others Product Picture
Figure United States Marburg Hemorrhagic Fever Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Marburg Hemorrhagic Fever Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Marburg Hemorrhagic Fever Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Marburg Hemorrhagic Fever Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Marburg Hemorrhagic Fever Drug Sales Share by Players/Suppliers
Figure 2017 United States Marburg Hemorrhagic Fever Drug Sales Share by Players/Suppliers
Figure United States Marburg Hemorrhagic Fever Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Marburg Hemorrhagic Fever Drug Revenue Share by Players/Suppliers
Figure 2017 United States Marburg Hemorrhagic Fever Drug Revenue Share by Players/Suppliers
Table United States Market Marburg Hemorrhagic Fever Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Marburg Hemorrhagic Fever Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Marburg Hemorrhagic Fever Drug Market Share of Top 3 Players/Suppliers
Figure United States Marburg Hemorrhagic Fever Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Marburg Hemorrhagic Fever Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Marburg Hemorrhagic Fever Drug Product Category
Table United States Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Region (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales Share by Region (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Share by Region (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Market Share by Region in 2017
Table United States Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Revenue Share by Region (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Revenue Market Share by Region in 2017
Table United States Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Type (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales Share by Type (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Share by Type (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Market Share by Type in 2017
Table United States Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Marburg Hemorrhagic Fever Drug by Type (2013-2018)
Figure Revenue Market Share of Marburg Hemorrhagic Fever Drug by Type in 2017
Table United States Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Growth Rate by Type (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Application (2013-2018)
Table United States Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Market Share by Application in 2017
Table United States Marburg Hemorrhagic Fever Drug Sales Growth Rate by Application (2013-2018)
Figure United States Marburg Hemorrhagic Fever Drug Sales Growth Rate by Application (2013-2018)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Immunovaccine, Inc. Basic Information List
Table Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Integrated BioTherapeutics, Inc. Basic Information List
Table Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Sarepta Therapeutics, Inc. Basic Information List
Table Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Tekmira Pharmaceuticals Corp. Basic Information List
Table Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Vaxart, Inc Basic Information List
Table Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales Growth Rate (2013-2018)
Figure Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales Market Share in United States (2013-2018)
Figure Vaxart, Inc Marburg Hemorrhagic Fever Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Marburg Hemorrhagic Fever Drug
Figure Manufacturing Process Analysis of Marburg Hemorrhagic Fever Drug
Figure Marburg Hemorrhagic Fever Drug Industrial Chain Analysis
Table Raw Materials Sources of Marburg Hemorrhagic Fever Drug Major Players/Suppliers in 2017
Table Major Buyers of Marburg Hemorrhagic Fever Drug
Table Distributors/Traders List
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Marburg Hemorrhagic Fever Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Marburg Hemorrhagic Fever Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Marburg Hemorrhagic Fever Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications